Together, these results suggest that CASP1 represents an RNA-level actionable target, whereas WDR6 reflects germline genetic liability, offering complementary therapeutic and mechanistic insights into IBD/MDD comorbidity. The gene discussed is WDR6; the disease is major depressive disorder.